Target intelligence / Profile preview

Myelination promotion

Molecular classification
Other
01

Overview

Myelination promotion is a term used to describe the enhancement or stimulation of the process by which oligodendrocytes form and wrap myelin sheaths around axons, thereby facilitating rapid nerve impulse conduction in the central nervous system[1][2][3][4][5]. This process is modulated by numerous molecular signals, cellular interactions (including with astrocytes and neurons), and environmental factors such as neuronal activity and growth factors. Myelination abnormalities contribute to neurodegenerative and demyelinating diseases, making the promotion of myelination a therapeutic goal in conditions like multiple sclerosis. However, "myelination promotion" itself is not a discrete molecular target, receptor, or druggable entity, but a complex biological endpoint resulting from many interacting pathways.

Other names
Myelin formation promotionPromotion of myelinationMyelinogenesis enhancement
02

Mechanism of action

Various mechanisms, including regulation of oligodendrocyte precursor cell differentiation, modulation of signaling pathways such as Notch, growth factor signaling, and neuronal activity-induced signaling.

03

Biological functions

Myelin sheath formationAxonal insulationIncreased nerve conduction velocityOligodendrocyte differentiation
04

Disease associations

Neurodegenerative diseaseDemyelinating disordersMultiple sclerosisLeukodystrophiesCNS injury
05

Safety considerations

Varies by therapeutic strategyContext-dependentNot specific to a single molecule
06

Interacting drugs

clemastine

2 more in the full profile.

07

Biomarkers

myelin basic protein (MBP)oligodendrocyte lineage markers

Beyond the preview

Go deeper on Myelination promotion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myelination promotion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call